CASI Pharmaceuticals
CASI
#8749
Rank
S$0.11 B
Marketcap
$7.18
Share price
-7.55%
Change (1 day)
105.22%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -S$36.27 M

According to CASI Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -S$35.06 M. In 2023 the company made an earning of -S$34.36 M an increase over its 2022 earnings that were of -S$48.76 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$36.27 M5.59%
2023 -S$34.36 M-29.55%
2022 -S$48.76 M4.43%
2021 -S$46.69 M-24.56%
2020 -S$61.89 M4.74%
2019 -S$59.09 M65.13%
2018 -S$35.79 M155.07%
2017 -S$14.03 M13.93%
2016 -S$12.32 M31.18%
2015 -S$9.39 M-72.5%
2014 -S$34.13 M356.62%
2013 -S$7.48 M-60.55%
2012 -S$18.95 M218.41%
2011 -S$5.95 M0.74%
2010 -S$5.91 M-32.54%
2009 -S$8.76 M-66.98%
2008 -S$26.52 M-14.22%
2007 -S$30.91 M7.04%
2006 -S$28.88 M27.95%
2005 -S$22.57 M4.51%
2004 -S$21.6 M-15.84%
2003 -S$25.66 M-55.29%
2002 -S$57.4 M-34.05%
2001 -S$87.03 M31.73%
2000 -S$66.07 M31.56%
1999 -S$50.22 M145.56%
1998 -S$20.45 M76.4%
1997 -S$11.6 M36.92%
1996 -S$8.47 M